Common Sense Oncology leadership team is having its first annual meeting next week in Montreal. Our opening plenary session will be open to all CSO members. Join us by zoom for the LIVE plenary session with these leaders in our field.
Register for zoom link here-

Are you an early to mid-career cancer researcher in the UK? Don't miss this opportunity to apply to spend 6-12 months National Cancer Institute. Match-making support provided by NCI through June 7, 2024. Register today for the pre-application webinar on 4/25/24 @ 9am ET bit.ly/DSE-webinar

Important insights on cancer stigma in India from my wonderful colleague Ishu Kataria and colleagues. Measurement of cancer stigma in India: challenges and opportunities sciencedirect.com/science/articl…
See also thelancet.com/commissions/wo…. Ophira Ginsburg

Some very important findings here from Enrique Soto & colleagues. While living longer is certainly an important goal for older patients on chemotherapy, living well, independence of living and cognition while alive were very important, sometimes even when it meant living shorter

An important article was published today that everyone should read about the persisting gaps in female authorship in oncology worldwide. Miriam Mutebi Ophira Ginsburg Richard Sullivan BMJ Oncology

Article: bmjoncology.bmj.com/content/3/1/e0…

My editorial:
bmjoncology.bmj.com/content/3/1/e0…

The The White House Global Health Security Strategy launched today outlines actions the U.S. government will take to ensure our nation is prepared for a future pandemic and biological threats. Department of State Bureau of #GlobalHealthSecurity and Diplomacy is coordinating efforts across the

6 days to go 🚨

Our Commission on #BreastCancer will be launched April 16.

Register to hear from authors, special guests & Lancet editors on the key challenges in breast cancer & how to address them 🔽 hubs.li/Q02smMB80

The Lancet Commission on prostate cancer projects a X2️⃣ 📈of cases by 2040, highlighting the urgent need for innovations in diagnosis & treatment.
👏Kudos to the authors for mapping a path to better men’s health worldwide.

OncoAlert Prostate Cancer Foundation Nick James Advanced Prostate Cancer Consensus Conference

Join us Thursday at 10 AM ET for our first Global Cancer Research and Control Seminar of 2024, featuring Dr Olusegun Alatise and Peter Kingham as they discuss their work on #ColorectalCancer in Nigeria. Register today! bit.ly/gcrcss

Check out this job at World Health Organization: Director, Noncommunicable Diseases Without bias😉 The most exciting job in the Global Public Health world- please apply!!! linkedin.com/jobs/view/3881…

🌍 New global cancer statistics from American Cancer Society & IARC reveal that ~20 million new cancer cases were diagnosed in 2022 and 9.7 million people died from the disease worldwide. Cancer cases are predicted to reach 35 million by 2050.

acsjournals.onlinelibrary.wiley.com/doi/10.3322/ca…

OncoAlert

Safety, quality improvement, and cost effectiveness should be mandatory teaching material in medical education. Probably more important than learning about the Kreb's cycle.

Prostate cancer is the most common cancer in men in over 100 countries worldwide. This burden will increase and is not avoidable. Ageing and genetics are the major determinants. The Lancet commission on Prostate cancer makes a plan on how to prepare for the surge of new cases👇

Excited to see this published and even more excited to continue our work at NCI Center for Global Health to improve equity in global cancer research

Important work by a fantastic team at the NCI Center for Global Health Linsey Eldridge Elise M. Garton Satish Gopal, MD, MPH

Global oncology follows the familiar pattern

'LMIC-affiliated authors are underrepresented on publications supported by NCI-funded grants involving LMICs'

jamanetwork.com/journals/jaman…